Sernova Biotherapeutics Inc Stock
Stocks
SVA
CA81752F1062
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-09-28
|
5-day change | 1st Jan Change | ||
| 0.0900 CAD | 0.00% |
|
-14.29% | -30.77% |
| Market Cap | 33.99M 23.99M 21.1M 19.95M 18.1M 2.3B 34.19M 239M 92.27M 1.18B 90.07M 88.12M 3.78B | P/E 2026 * |
-3.6x | P/E 2027 * | -3x |
|---|---|---|---|---|---|
| Enterprise Value | 33.99M 23.99M 21.1M 19.95M 18.1M 2.3B 34.19M 239M 92.27M 1.18B 90.07M 88.12M 3.78B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.6x |
| Free-Float |
89.49% | Yield 2026 * |
-
| Yield 2027 * | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| SVA | End-of-day quote | |
Toronto S.E.
| SVA | Delayed | |
|
Tradegate
| PSH0 | Real-time | |
|
Xetra
| PSH0 | Delayed | |
|
OTC Markets
| SEOVF | Delayed | |
|
Deutsche Boerse AG
| PSH0 | Delayed | |
|
Börse Stuttgart
| PSH0 | Delayed | |
|
Boerse Muenchen
| PSH0 | Real-time |
| 1 week | -14.29% | ||
| Current month | -18.18% | ||
| 1 month | -18.18% | ||
| 3 months | -35.71% | ||
| 6 months | -47.06% | ||
| Current year | -30.77% |
| 1 week | 0.08 |  | 0.1 |
| 1 month | 0.08 | | 0.15 |
| Current year | 0.08 | | 0.2 |
| 1 year | 0.08 | | 0.2 |
| 3 years | 0.08 | | 0.82 |
| 5 years | 0.08 | | 2.22 |
| 10 years | 0.08 | | 2.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Rigby
CEO | Chief Executive Officer | 58 | 2024-08-11 |
James Parsons
DFI | Director of Finance/CFO | 60 | 2024-10-10 |
David Burke
IRC | Investor Relations Contact | - | 2024-10-10 |
| Director | Title | Age | Since |
|---|---|---|---|
James Parsons
BRD | Director/Board Member | 60 | 2012-04-18 |
Steven Sangha
BRD | Director/Board Member | - | 2023-04-23 |
David Paterson
BRD | Director/Board Member | - | 2024-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 7/3/26 | Sell | Company | -115,000 | 0.0305% | ||
| 5/22/26 | Option | Chairman | 228,912 | 0.0658% | ||
| 5/22/26 | Option | Director | 260,000 | 0.0748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -14.29% | -51.35% | -88.16% | 23.99M | |
| +1.08% | +0.41% | -25.39% | +0.69% | 106B | |
| +0.05% | -1.70% | -23.49% | -0.98% | 11.29B | |
| +2.67% | -1.84% | +98.40% | +108.08% | 9.35B | |
| -0.68% | -2.36% | -49.71% | -67.13% | 4.11B | |
| -0.10% | +4.24% | -22.13% | +26.96% | 2.49B | |
| -0.71% | -7.55% | -9.37% | -65.07% | 2.02B | |
| -2.05% | -2.61% | - | - | 1.9B | |
| -0.80% | -2.03% | -22.63% | -32.22% | 1.52B | |
| Average | -0.22% | -2.65% | -13.21% | -14.73% | 15.37B | |
| Weighted average by Cap. | -0.18% | -0.15% | -17.16% | +4.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 2.5M 1.76M 1.55M 1.47M 1.33M 169M 2.51M 17.57M 6.79M 86.44M 6.63M 6.48M 278M |
| Net income | -11.3M -7.98M -7.02M -6.63M -6.02M -766M -11.37M -79.43M -30.68M -391M -29.95M -29.3M -1.26B | -13.9M -9.81M -8.63M -8.16M -7.4M -942M -13.98M -97.7M -37.73M -481M -36.84M -36.04M -1.54B |
| Net Debt | - | - |
Employees
8
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-28 | $0.0900 | 0.00% | 284,163 |
| 26-09-25 | $0.0900 | 0.00% | 77,027 |
| 26-09-24 | $0.0900 | -5.26% | 721,169 |
| 26-09-23 | $0.0950 | -5.00% | 455,403 |
| 26-09-22 | $0.1000 | -4.76% | 156,902 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.0900CAD
Average target price
1.000CAD
Spread / Average Target
+1,011.11%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SVA Stock
Select your edition
All financial news and data tailored to specific country editions
